IBDEI0L8 ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1176,0)
 ;;=ENCEPALOPATHY^4^125
 ;;^UTILITY(U,$J,358.4,1177,0)
 ;;=SPINAL CONDITIONS^14^125
 ;;^UTILITY(U,$J,358.4,1178,0)
 ;;=VISION DISTURBANCES^16^125
 ;;^UTILITY(U,$J,358.4,1179,0)
 ;;=MOVEMENT DISORDERS^15^125
 ;;^UTILITY(U,$J,358.4,1180,0)
 ;;=OTHER^13^125
 ;;^UTILITY(U,$J,358.4,1181,0)
 ;;=CARDIAC DISORDERS^1^125
 ;;^UTILITY(U,$J,358.4,1182,0)
 ;;=NEOPLASMS^8^125
 ;;^UTILITY(U,$J,358.4,1183,0)
 ;;=SYMPTOMS^17^125
 ;;^UTILITY(U,$J,358.4,1184,0)
 ;;=NEUROLOGY/SEIZURE^1^126
 ;;^UTILITY(U,$J,358.4,1185,0)
 ;;=EEG^2^126
 ;;^UTILITY(U,$J,358.4,1186,0)
 ;;=SLEEP TESTING^3^126
 ;;^UTILITY(U,$J,358.4,1187,0)
 ;;=MUSCLE TESTING/EMG^4^126
 ;;^UTILITY(U,$J,358.4,1188,0)
 ;;=EVOKED POTENTIAL^5^126
 ;;^UTILITY(U,$J,358.4,1189,0)
 ;;=BIOPSY^5.5^126
 ;;^UTILITY(U,$J,358.4,1190,0)
 ;;=AUTONOMIC FUNCTION TESTS^8^126
 ;;^UTILITY(U,$J,358.4,1191,0)
 ;;=ESTABLISHED PATIENT^2^127
 ;;^UTILITY(U,$J,358.4,1192,0)
 ;;=INJECTIONS/MEDICATION^10^128
 ;;^UTILITY(U,$J,358.4,1193,0)
 ;;=OTHER^11^128
 ;;^UTILITY(U,$J,358.4,1194,0)
 ;;=ALLERGY INJECTION^1^128
 ;;^UTILITY(U,$J,358.4,1195,0)
 ;;=INJECTION ADMINISTRATION^9^128
 ;;^UTILITY(U,$J,358.4,1196,0)
 ;;=IMMUNIZATION ADMINISTRATION ^6^128
 ;;^UTILITY(U,$J,358.4,1197,0)
 ;;=CATHETER^2^128
 ;;^UTILITY(U,$J,358.4,1198,0)
 ;;=CATH FLUSHES^3^128
 ;;^UTILITY(U,$J,358.4,1199,0)
 ;;=PFT^12^128
 ;;^UTILITY(U,$J,358.4,1200,0)
 ;;=EKG/HOLTER MONITOR^5^128
 ;;^UTILITY(U,$J,358.4,1201,0)
 ;;=IMMUNIZATIONS^7^128
 ;;^UTILITY(U,$J,358.4,1202,0)
 ;;=INFUSIONS^8^128
 ;;^UTILITY(U,$J,358.4,1203,0)
 ;;=PICC^13^128
 ;;^UTILITY(U,$J,358.4,1204,0)
 ;;=SMOKING CESSATION^14^128
 ;;^UTILITY(U,$J,358.4,1205,0)
 ;;=CHEMO AND OTH COMPLEX DRUGS^4^128
 ;;^UTILITY(U,$J,358.4,1206,0)
 ;;=SIGNS AND SYMPTOMS^1^129
 ;;^UTILITY(U,$J,358.4,1207,0)
 ;;=CARDIO/VASCULAR^2^129
 ;;^UTILITY(U,$J,358.4,1208,0)
 ;;=ENDOCRINE, METOBOLIC, NUTRITIONAL^4^129
 ;;^UTILITY(U,$J,358.4,1209,0)
 ;;=EYES, EARS, & NOSE^5^129
 ;;^UTILITY(U,$J,358.4,1210,0)
 ;;=GASTROINTESTINAL^6^129
 ;;^UTILITY(U,$J,358.4,1211,0)
 ;;=GENITOURINARY & RENAL^7^129
 ;;^UTILITY(U,$J,358.4,1212,0)
 ;;=MUSCULOSKETAL^9^129
 ;;^UTILITY(U,$J,358.4,1213,0)
 ;;=NEUROLOGY^10^129
 ;;^UTILITY(U,$J,358.4,1214,0)
 ;;=PULMONARY/RESPIRATORY^14^129
 ;;^UTILITY(U,$J,358.4,1215,0)
 ;;=PSYCHIATRIC^15^129
 ;;^UTILITY(U,$J,358.4,1216,0)
 ;;=SKIN^16^129
 ;;^UTILITY(U,$J,358.4,1217,0)
 ;;=IMMUNIZATIONS^8^129
 ;;^UTILITY(U,$J,358.4,1218,0)
 ;;=OTHER^12^129
 ;;^UTILITY(U,$J,358.4,1219,0)
 ;;=PREVENTIVE MEDICINE CODES^13^129
 ;;^UTILITY(U,$J,358.4,1220,0)
 ;;=NURSING MISCELLANEOUS^11^129
 ;;^UTILITY(U,$J,358.4,1221,0)
 ;;=COUNSELING^3^129
 ;;^UTILITY(U,$J,358.4,1222,0)
 ;;=CONTACT W/ HAZARDOUS SUBSTANCES^.5^129
 ;;^UTILITY(U,$J,358.4,1223,0)
 ;;=SPECIAL SERVICES^6^130
 ;;^UTILITY(U,$J,358.4,1224,0)
 ;;=TREATMENT^7^130
 ;;^UTILITY(U,$J,358.4,1225,0)
 ;;=MISCELLANEOUS^5^130
 ;;^UTILITY(U,$J,358.4,1226,0)
 ;;=IMMUNIZATIONS^4^130
 ;;^UTILITY(U,$J,358.4,1227,0)
 ;;=CHEMO ADMINISTRATION^1^130
 ;;^UTILITY(U,$J,358.4,1228,0)
 ;;=CHEMO DRUGS^2^130
 ;;^UTILITY(U,$J,358.4,1229,0)
 ;;=OTHER DRUGS^3^130
 ;;^UTILITY(U,$J,358.4,1230,0)
 ;;=NEW PATIENT^2^131
 ;;^UTILITY(U,$J,358.4,1231,0)
 ;;=ESTABLISHED PATIENT^1^131
 ;;^UTILITY(U,$J,358.4,1232,0)
 ;;=CONSULTATIONS^3^131
 ;;^UTILITY(U,$J,358.4,1233,0)
 ;;=ANEMIA^1^132
 ;;^UTILITY(U,$J,358.4,1234,0)
 ;;=COAGULATION DISORDERS^4^132
 ;;^UTILITY(U,$J,358.4,1235,0)
 ;;=MYELOID NEOPLASMS & DISORDERS^12^132
 ;;^UTILITY(U,$J,358.4,1236,0)
 ;;=LYMPHOID NEOPLASMS^9^132
 ;;^UTILITY(U,$J,358.4,1237,0)
 ;;=GI NEOPLASMS^7^132
 ;;^UTILITY(U,$J,358.4,1238,0)
 ;;=HEAD, NECK & LUNG NEOPLASMS^8^132
 ;;^UTILITY(U,$J,358.4,1239,0)
 ;;=MISC. NEOPLASMS^11^132
 ;;^UTILITY(U,$J,358.4,1240,0)
 ;;=METASTATIC SITES^10^132
 ;;^UTILITY(U,$J,358.4,1241,0)
 ;;=COUNSELING & SCREENING^5^132
 ;;^UTILITY(U,$J,358.4,1242,0)
 ;;=GENITOURINARY NEOPLASMS^6^132
 ;;^UTILITY(U,$J,358.4,1243,0)
 ;;=BREAST & GYN NEOPLASMS^3^132
 ;;^UTILITY(U,$J,358.4,1244,0)
 ;;=ARTIFICIAL OPENING STATUS^2^132
 ;;^UTILITY(U,$J,358.4,1245,0)
 ;;=PERSONAL HX OF CANCER^15^132
 ;;^UTILITY(U,$J,358.4,1246,0)
 ;;=NEOPLASMS OF UNCERTAIN BEHAVIOR^13^132
 ;;^UTILITY(U,$J,358.4,1247,0)
 ;;=NEOPLASMS OF UNSPECIFIED NATURE^14^132
 ;;^UTILITY(U,$J,358.4,1248,0)
 ;;=ESTABLISHED PATIENT^1^133
 ;;^UTILITY(U,$J,358.4,1249,0)
 ;;=CONSULTATION-CLINICIAN^2^133
 ;;^UTILITY(U,$J,358.4,1250,0)
 ;;=NEW PATIENT^3^133
 ;;^UTILITY(U,$J,358.4,1251,0)
 ;;=NEUROLYSIS^1^134
 ;;^UTILITY(U,$J,358.4,1252,0)
 ;;=NEUROSTIMULATORS^2^134
 ;;^UTILITY(U,$J,358.4,1253,0)
 ;;=OTHER PROCEDURES^3^134
 ;;^UTILITY(U,$J,358.4,1254,0)
 ;;=SPINAL PROCEDURES/NERVE BLOCKS^4^134
 ;;^UTILITY(U,$J,358.4,1255,0)
 ;;=SYMPTOMS^5^135
 ;;^UTILITY(U,$J,358.4,1256,0)
 ;;=ESTHESOPATHIES & ALLIED SYNDROMES^1^135
 ;;^UTILITY(U,$J,358.4,1257,0)
 ;;=HEADACHE^2^135
 ;;^UTILITY(U,$J,358.4,1258,0)
 ;;=SPINAL CONDITIONS^4^135
 ;;^UTILITY(U,$J,358.4,1259,0)
 ;;=PAIN^3^135
 ;;^UTILITY(U,$J,358.4,1260,0)
 ;;=INPT H&P-NEW ADMISSION^2^136
 ;;^UTILITY(U,$J,358.4,1261,0)
 ;;=INITIAL OBSERVATION^1^136
 ;;^UTILITY(U,$J,358.4,1262,0)
 ;;=INPT CONSULTATIONS^3^136
 ;;^UTILITY(U,$J,358.4,1263,0)
 ;;=INPT - ESTABLISHED PATIENT CARE^4^136
 ;;^UTILITY(U,$J,358.4,1264,0)
 ;;=INPATIENT DISCHARGES^5^136
 ;;^UTILITY(U,$J,358.4,1265,0)
 ;;=INJECTIONS/DRUGS^2^137
 ;;^UTILITY(U,$J,358.4,1266,0)
 ;;=WOUND CARE^5^137
 ;;^UTILITY(U,$J,358.4,1267,0)
 ;;=MD PROCEDURES^1^137
 ;;^UTILITY(U,$J,358.4,1268,0)
 ;;=MUSCLE NERVE TESTS^3^137
 ;;^UTILITY(U,$J,358.4,1269,0)
 ;;=TEAM CONFERENCE^4^137
 ;;^UTILITY(U,$J,358.4,1270,0)
 ;;=V CODES ^19^138
 ;;^UTILITY(U,$J,358.4,1271,0)
 ;;=AMPUTATION STATUS^3^138
 ;;^UTILITY(U,$J,358.4,1272,0)
 ;;=BRAIN DISORDERS^6^138
 ;;^UTILITY(U,$J,358.4,1273,0)
 ;;=CARDIOPULMONARY^7^138
 ;;^UTILITY(U,$J,358.4,1274,0)
 ;;=COMPLICATION DUE TO^9^138
 ;;^UTILITY(U,$J,358.4,1275,0)
 ;;=FRACTURES-LATE EFFECTS^11^138
 ;;^UTILITY(U,$J,358.4,1276,0)
 ;;=MENTAL DISORDERS^12^138
 ;;^UTILITY(U,$J,358.4,1277,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^13^138
 ;;^UTILITY(U,$J,358.4,1278,0)
 ;;=LATE EFFECTS OF INJURY^1^138
 ;;^UTILITY(U,$J,358.4,1279,0)
 ;;=LATE EFFECTS OF CVA^2^138
 ;;^UTILITY(U,$J,358.4,1280,0)
 ;;=PHYSICAL CHANGES^15^138
 ;;^UTILITY(U,$J,358.4,1281,0)
 ;;=SPEECH AND LANGUAGE^18^138
 ;;^UTILITY(U,$J,358.4,1282,0)
 ;;=AUDITORY^4^138
 ;;^UTILITY(U,$J,358.4,1283,0)
 ;;=COGNITION^8^138
 ;;^UTILITY(U,$J,358.4,1284,0)
 ;;=PSYCHIATRIC-PSYCHOSOC-EMOTIONAL^17^138
 ;;^UTILITY(U,$J,358.4,1285,0)
 ;;=BACK DIAGNOSIS^5^138
 ;;^UTILITY(U,$J,358.4,1286,0)
 ;;=EXTREMITY DIAGNOSIS^10^138
 ;;^UTILITY(U,$J,358.4,1287,0)
 ;;=POST JOINT REPLACEMENT^16^138
 ;;^UTILITY(U,$J,358.4,1288,0)
 ;;=OTHER^14^138
 ;;^UTILITY(U,$J,358.4,1289,0)
 ;;=INITIAL EVAL FOR TBI^1^139
 ;;^UTILITY(U,$J,358.4,1290,0)
 ;;=EST PATIENT^1^140
 ;;^UTILITY(U,$J,358.4,1291,0)
 ;;=NEW PATIENT^2^140
 ;;^UTILITY(U,$J,358.4,1292,0)
 ;;=CONSULTATION^3^140
 ;;^UTILITY(U,$J,358.4,1293,0)
 ;;=INJECTIONS/DRUGS^3^141
 ;;^UTILITY(U,$J,358.4,1294,0)
 ;;=WOUND CARE^6^141
 ;;^UTILITY(U,$J,358.4,1295,0)
 ;;=MD PROCEDURES^2^141
 ;;^UTILITY(U,$J,358.4,1296,0)
 ;;=MUSCLE NERVE TESTS^4^141
 ;;^UTILITY(U,$J,358.4,1297,0)
 ;;=TEAM CONFERENCE^5^141
 ;;^UTILITY(U,$J,358.4,1298,0)
 ;;=OBSERVATION^1^141
 ;;^UTILITY(U,$J,358.4,1299,0)
 ;;=V CODES ^19^142
 ;;^UTILITY(U,$J,358.4,1300,0)
 ;;=AMPUTATION STATUS^3^142
 ;;^UTILITY(U,$J,358.4,1301,0)
 ;;=BRAIN DISORDERS^6^142
 ;;^UTILITY(U,$J,358.4,1302,0)
 ;;=CARDIOPULMONARY^7^142
 ;;^UTILITY(U,$J,358.4,1303,0)
 ;;=COMPLICATION DUE TO^9^142
 ;;^UTILITY(U,$J,358.4,1304,0)
 ;;=FRACTURES-LATE EFFECTS^11^142
 ;;^UTILITY(U,$J,358.4,1305,0)
 ;;=MENTAL DISORDERS^12^142
 ;;^UTILITY(U,$J,358.4,1306,0)
 ;;=MUSCULOSKELETAL/CONNECTIVE TISSUE^13^142
 ;;^UTILITY(U,$J,358.4,1307,0)
 ;;=LATE EFFECTS OF INJURY^1^142
 ;;^UTILITY(U,$J,358.4,1308,0)
 ;;=LATE EFFECTS OF CVA^2^142
 ;;^UTILITY(U,$J,358.4,1309,0)
 ;;=PHYSICAL CHANGES^15^142
 ;;^UTILITY(U,$J,358.4,1310,0)
 ;;=SPEECH AND LANGUAGE^18^142
 ;;^UTILITY(U,$J,358.4,1311,0)
 ;;=AUDITORY^4^142
 ;;^UTILITY(U,$J,358.4,1312,0)
 ;;=COGNITION^8^142
 ;;^UTILITY(U,$J,358.4,1313,0)
 ;;=PSYCHIATRIC-PSYCHOSOC-EMOTIONAL^17^142
 ;;^UTILITY(U,$J,358.4,1314,0)
 ;;=BACK DIAGNOSIS^5^142
 ;;^UTILITY(U,$J,358.4,1315,0)
 ;;=EXTREMITY DIAGNOSIS^10^142
 ;;^UTILITY(U,$J,358.4,1316,0)
 ;;=POST JOINT REPLACEMENT^16^142
 ;;^UTILITY(U,$J,358.4,1317,0)
 ;;=OTHER^14^142
 ;;^UTILITY(U,$J,358.4,1318,0)
 ;;=INITIAL EVAL FOR TBI^1^143
 ;;^UTILITY(U,$J,358.4,1319,0)
 ;;=NEW PATIENT^2^144
 ;;^UTILITY(U,$J,358.4,1320,0)
 ;;=ESTABLISHED PATIENT^1^144
 ;;^UTILITY(U,$J,358.4,1321,0)
 ;;=CONSULTATIONS^3^144
 ;;^UTILITY(U,$J,358.4,1322,0)
 ;;=GLOBAL FOLLOW UP^4^144
 ;;^UTILITY(U,$J,358.4,1323,0)
 ;;=DIAGNOSIS^1^145
 ;;^UTILITY(U,$J,358.4,1324,0)
 ;;=OFFICE PROCEDURES^1^146
 ;;^UTILITY(U,$J,358.4,1325,0)
 ;;=NEW PATIENT^2^147
 ;;^UTILITY(U,$J,358.4,1326,0)
 ;;=ESTABLISHED PATIENT^1^147
 ;;^UTILITY(U,$J,358.4,1327,0)
 ;;=CONSULTATIONS^3^147
 ;;^UTILITY(U,$J,358.4,1328,0)
 ;;=NEURO^5^148
 ;;^UTILITY(U,$J,358.4,1329,0)
 ;;=MENTAL HEALTH^4^148
 ;;^UTILITY(U,$J,358.4,1330,0)
 ;;=HISTORY OF ILLNESS^3^148
 ;;^UTILITY(U,$J,358.4,1331,0)
 ;;=PREVENTIVE HEALTH/SCREENINGS^6^148
 ;;^UTILITY(U,$J,358.4,1332,0)
 ;;=SIGNS, SYMPTOMS, CONDITIONS^7^148
 ;;^UTILITY(U,$J,358.4,1333,0)
 ;;=OTHER REASONS^8^148
 ;;^UTILITY(U,$J,358.4,1334,0)
 ;;=TBI SCREENING^1^148
 ;;^UTILITY(U,$J,358.4,1335,0)
 ;;=CAUSES OF INJURY (SECONDARY DX ONLY)^9^148
 ;;^UTILITY(U,$J,358.4,1336,0)
 ;;=HEADACHES^2^148
 ;;^UTILITY(U,$J,358.4,1337,0)
 ;;=IMMUNIZATIONS^4^149
 ;;^UTILITY(U,$J,358.4,1338,0)
 ;;=PT/KT/OT^5^149
 ;;^UTILITY(U,$J,358.4,1339,0)
 ;;=TESTING^6^149
 ;;^UTILITY(U,$J,358.4,1340,0)
 ;;=IMMUNIZATION ADMINISTRATION^3^149
 ;;^UTILITY(U,$J,358.4,1341,0)
 ;;=COUNSELING^1^149
 ;;^UTILITY(U,$J,358.4,1342,0)
 ;;=EDUCATION^2^149
